Choosing and Salvaging an Ambulatory Monitor Study
A 38-year-old teacher is referred for palpitations that occur two to three times a week and last "a minute or two." Her resting 12-lead, thyroid studies and exam are normal. She takes metoprolol for migraine prophylaxis. She has sensitive skin, works full time, showers daily, and coaches soccer twice a week. The ordering provider has requested a 24-hour Holter monitor, and the scheduler asks you whether to book it as ordered.
1. Is a 24-hour Holter the right test here? Build the argument, and name what you would propose instead.
Read the worked answer
The question is not "which monitor is best" - it is "what is the probability this recording captures a symptom?"
- Her episodes occur 2–3 times per week, each lasting 1–2 minutes. In 24 hours the expected number of episodes is roughly 0.3–0.9. That means a substantial chance - well over half - that the 24-hour recording contains no symptom at all, and the study yields a normal tracing and an unanswered question.
- The monitor must also capture the symptom, not just any rhythm. A 24-hour Holter is well suited to daily or near-daily symptoms, or to quantifying burden of a known arrhythmia.
- Proposal: a prolonged monitor with patient-triggered event capture. A 2-week continuous patch or a 30-day event monitor is a better match: brief episodes that the patient can trigger, frequent enough to recur within days, and a long enough window to make capture likely. Her symptoms last a minute or two - long enough for her to press a button mid-episode.
- Route the suggestion correctly: you do not simply override the order. Flag it to the ordering provider with the reasoning (frequency of symptoms vs. monitoring window) and let the order be changed deliberately; document the conversation.
- Also worth surfacing: metoprolol may be suppressing or altering the episodes, so the study may underestimate the arrhythmia - information the interpreting physician needs.
2. Write the patient instructions you would give, ordered by which ones most determine whether the study is usable.
Read the worked answer
Tier 1 - kill the artifacts before they happen:
- No showering, bathing, swimming or hot tubs while wearing the monitor. Sponge baths only, below the electrodes. Water degrades the adhesive and the signal.
- No lotions, powders, oils or sunscreen on the chest before or during the study.
- Do not remove or reposition the leads, and do not disconnect the recorder. If an electrode lifts, note the time in the diary and call the lab number - do not improvise with tape over a wet electrode.
- Wear a loose cotton shirt and route the cable inside clothing so it is not snagged or pulled.
Tier 2 - make the diary worth reading: 5. Record the time and description of every palpitation episode, plus what you were doing (climbing stairs, coaching, lying down) and how long it lasted and how it resolved. 6. Note medication times, including her metoprolol. 7. Press the event button whenever symptoms occur, and record the time. 8. Note sleep and wake times - nocturnal and early-morning arrhythmias mean different things.
Tier 3 - participation and safety: 9. Continue normal activity, including soccer - but expect sweat to loosen adhesive; bring it up at hook-up so the tech can secure it with extra tape or a cohesive wrap. 10. Avoid MRI, high-voltage equipment, electric blankets and heavy magnets; keep the recorder dry and away from direct heat. 11. Her sensitive skin warrants a hypoallergenic electrode and instruction to call if itching, blistering or redness develops rather than simply tearing the device off. 12. Call the lab for: chest pain, fainting, severe palpitations - and for the emergency services first if she feels faint or has chest pain, not the monitor hotline.
3. The study returns with three diary entries (identical description of her usual palpitations) and one 12-second run of irregular narrow-complex tachycardia that matches no diary entry. About 35% of the tracing is noise in one channel from a loose electrode. Is the study negative, positive, or non-diagnostic, and what do you recommend?
Read the worked answer
It is neither cleanly negative nor cleanly positive - it is a partially interpretable study with two separate findings.
On technical quality: 35% artifact confined to one channel is usually still interpretable if the second channel is clean, and two channels are recorded for exactly this reason. Review the artifact periods against the diary - if the noisy window covers any of her three symptom entries, those entries are uninterpretable and the study loses its main purpose.
On the symptom correlation:
- Three symptomatic entries with no rhythm change means her palpitations were not caused by an arrhythmia during those episodes - reassuring but not conclusive over 24 hours (or however long the study ran), given how rarely she has episodes.
- The 12-second asymptomatic irregular narrow-complex run is a real finding that needs physician interpretation: is it atrial fibrillation, multifocal atrial tachycardia, or a run of PACs? Asymptomatic arrhythmia still matters - it may change management if it is AF.
What you do (tech role, not diagnosis):
- Flag the asymptomatic run explicitly in the report routing so it is not buried in a long recording.
- Note the artifact percentage, which channel, and which diary entries fall inside it.
- Recommend to the ordering provider: repeat with better skin prep and electrode choice, and use a longer monitoring window - the 24-hour duration was the core limitation from the start.
- Recommend a 12-lead during or shortly after an episode if the asymptomatic run is confirmed as AF/SVT.
"Normal Holter" is the wrong summary for this study.